What's in Zensun Sci. & Tech. Co., Ltd.'s pipeline?

Zensun Sci. & Tech. Co., Ltd. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Zensun Sci. & Tech. Co., Ltd.'s portfolio?

Top competitors by shared drug class: Adocia, Australasian Gastro-Intestinal Trials Group, Centre Oscar Lambret, Chinese PLA General Hospital, Genzyme, a Sanofi Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/zensun-sci-tech-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Zensun Sci. & Tech. Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Zensun Sci. & Tech. Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Neucardin	Neucardin	phase 3			Other
Recombinant human Neuregulin for injection	Recombinant human Neuregulin for injection	phase 3	Growth factor	ErbB4	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Adocia · 1 shared drug class
Australasian Gastro-Intestinal Trials Group · 1 shared drug class
Centre Oscar Lambret · 1 shared drug class
Chinese PLA General Hospital · 1 shared drug class
Genzyme, a Sanofi Company · 1 shared drug class
Hyuk moon Kim · 1 shared drug class
SVS Institute of Dental Sciences · 1 shared drug class
Soligenix · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Zensun Sci. & Tech. Co., Ltd.:

Cite this brief

Drug Landscape (2026). Zensun Sci. & Tech. Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/zensun-sci-tech-co-ltd. Accessed 2026-06-09.